4//SEC Filing
Aurentz Vincent 4
Accession 0000950170-25-026650
CIK 0001750149other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 4:10 PM ET
Size
5.6 KB
Accession
0000950170-25-026650
Insider Transaction Report
Form 4
Aurentz Vincent
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-21+134,427→ 134,427 totalExercise: $2.23Exp: 2035-02-21→ Common Stock (134,427 underlying)
Footnotes (1)
- [F1]The options will vest and become exercisable in two substantially equal installments on the first and second anniversaries of February 21, 2025, subject to the Reporting Person's continued services through such date.
Documents
Issuer
Inhibikase Therapeutics, Inc.
CIK 0001750149
Entity typeother
Related Parties
1- filerCIK 0001657494
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 4:10 PM ET
- Size
- 5.6 KB